临床儿科杂志
臨床兒科雜誌
림상인과잡지
2009年
11期
1030-1035
,共6页
郭亚乐%黄绍平%李丹%杨琳%周戬平
郭亞樂%黃紹平%李丹%楊琳%週戩平
곽아악%황소평%리단%양림%주전평
环孢素A%癫(癎)%未成熟脑%星形胶质细胞纤维酸性蛋白%P-糖蛋白
環孢素A%癲(癎)%未成熟腦%星形膠質細胞纖維痠性蛋白%P-糖蛋白
배포소A%전(간)%미성숙뇌%성형효질세포섬유산성단백%P-당단백
eyclosporin A%epilepsy%immature brain%glial fibrillary acidic protein%P-glycoprotein
目的 探讨环孢素A(CsA)对未成熟脑惊厥性损伤的保护作用及机制.方法 21日龄SD雄性大鼠67只,制作氯化锂-匹鲁卡品癫(癎)模型,分别于制模后6、30、54 h采用CsA干预,分5、10、25 ms/(kg·次),三个干预剂量,与模型不干预组对比,观察制模后72 h脑海马CA1区凋亡细胞、多药耐药基因产物P-糖蛋白(P-gp)、星形胶质细胞纤维酸性蛋白(GFAP)表达情况等.结果 模型组比假手术组海马CA1区凋亡细胞、P-gP、GFAP表达明显增加,CsA 5 me,/(kg·次)干预组可显著减少P-gP、GFAP表达,且与假手术组水平接近,CsA 10 ms/(kg·次)、CsA 25 me,/(kg·次)有相似效果,但不及CsA 5 ms/(kg·次)效果明显.CsA干预不能减少凋亡细胞.结论 中小剂量CsA可以通过降低海马CA1区、P-gP、GFAP表达而减轻未成熟脑惊厥性损伤.
目的 探討環孢素A(CsA)對未成熟腦驚厥性損傷的保護作用及機製.方法 21日齡SD雄性大鼠67隻,製作氯化鋰-匹魯卡品癲(癎)模型,分彆于製模後6、30、54 h採用CsA榦預,分5、10、25 ms/(kg·次),三箇榦預劑量,與模型不榦預組對比,觀察製模後72 h腦海馬CA1區凋亡細胞、多藥耐藥基因產物P-糖蛋白(P-gp)、星形膠質細胞纖維痠性蛋白(GFAP)錶達情況等.結果 模型組比假手術組海馬CA1區凋亡細胞、P-gP、GFAP錶達明顯增加,CsA 5 me,/(kg·次)榦預組可顯著減少P-gP、GFAP錶達,且與假手術組水平接近,CsA 10 ms/(kg·次)、CsA 25 me,/(kg·次)有相似效果,但不及CsA 5 ms/(kg·次)效果明顯.CsA榦預不能減少凋亡細胞.結論 中小劑量CsA可以通過降低海馬CA1區、P-gP、GFAP錶達而減輕未成熟腦驚厥性損傷.
목적 탐토배포소A(CsA)대미성숙뇌량궐성손상적보호작용급궤제.방법 21일령SD웅성대서67지,제작록화리-필로잡품전(간)모형,분별우제모후6、30、54 h채용CsA간예,분5、10、25 ms/(kg·차),삼개간예제량,여모형불간예조대비,관찰제모후72 h뇌해마CA1구조망세포、다약내약기인산물P-당단백(P-gp)、성형효질세포섬유산성단백(GFAP)표체정황등.결과 모형조비가수술조해마CA1구조망세포、P-gP、GFAP표체명현증가,CsA 5 me,/(kg·차)간예조가현저감소P-gP、GFAP표체,차여가수술조수평접근,CsA 10 ms/(kg·차)、CsA 25 me,/(kg·차)유상사효과,단불급CsA 5 ms/(kg·차)효과명현.CsA간예불능감소조망세포.결론 중소제량CsA가이통과강저해마CA1구、P-gP、GFAP표체이감경미성숙뇌량궐성손상.
Objective To investigate the protective function and its mechanisms of eyclosporin A to immature brain tissue with convulsive brain damage. Methods 21-day-old SD rats were given lithium-pilocarpine to make the epilepsy model. Total 67 male rats had been investigated. Cyclosporin A (CsA) were injected three times at 6, 30, 54 hrs after model had been established. Three dosages had been chosen: 5, 10 and 25 mg/kg each time. The level of apoptotic cells, P-glycoprotein (P-gp), glial fibrillary acidic protein (GFAP) in CA1 area of hippocampus had been determined, and compared with the rats without giving CsA. Results Rats from epilepsy model group had higher level of apoptosis, P-gp, GFAP expression than those from pseudo-model group. CsA injection by dose 5 mg/kg each time for three times reduced the level of P-gp, GFAP. Model group and pseudo-model group were same. Both the interventions of CsA injection by 10 mg/kg and 25 mg/kg can reduce the level of P-gp, GFAP, however neither of their effectiveness was better than CsA 5 mg/kg each time. Conclusions Small dosage of CsA may protect the immature brain tissue from convulsive brain damage by reducing the level of P-gp, GFAP in CA1 area of hippocampus.